Company / R&D Expense
HARVARD BIOSCIENCE INC R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$10.4M
FY2025
5-year range
$8.7M / $12.3M
FY2021-FY2025
Trend
-11.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $5M in FY2016 to $12M in FY2023.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of -0.6%.
Declined from $12M to $10M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- -0.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.6%, indicating a declining trend.
- In FY2025, r&d expense decreased 11.5% year-over-year.
- Peak r&d expense was recorded in FY2023.
- Lowest r&d expense in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.4M | -11.5% |
| FY2024 | $11.8M | -4.6% |
| FY2023 | $12.3M | +14.2% |
| FY2022 | $10.8M | +24.3% |
| FY2021 | $8.7M | -18.9% |
| FY2020 | $10.7M | -2.5% |
| FY2019 | $11.0M | +94.7% |
| FY2018 | $5.6M | -12.1% |
| FY2017 | $6.4M | +31.6% |
| FY2016 | $4.9M | +17.5% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026